Viewing Study NCT05643794


Ignite Creation Date: 2025-12-25 @ 1:38 AM
Ignite Modification Date: 2026-01-04 @ 9:08 PM
Study NCT ID: NCT05643794
Status: COMPLETED
Last Update Posted: 2025-07-01
First Post: 2022-11-30
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Proof-of-concept Study to Evaluate the Efficacy and Safety of Rozanolixizumab to Treat Adult Study Participants With Severe Fibromyalgia Syndrome
Sponsor: UCB Biopharma SRL
Organization: